Finding biomarkers for early lung cancer spread patterns
Part of Cancer, Lungs & breathing clinical trials.
This study looks for biological markers (signs in blood or tissue) that predict how early-stage lung cancer spreads. If you have recently diagnosed lung cancer, this research could help doctors better understand your cancer and plan better treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have been newly diagnosed with early-stage lung adenocarcinoma (a type of lung cancer)
- You have not received any previous treatment for your lung cancer
- You can understand the study and provide informed consent
- You do not have inflammatory bowel disease or other autoimmune diseases
- You do not have active liver disease or a history of hepatitis
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at inherited genetic changes in people with a type of lung cancer called lung adenocarcinoma. The goal is to find gene variants linked to the disease, which may help guide future treatment decisions.
This study looks at how lung cancer spreads in people with early-stage non-small cell lung cancer. It may help doctors better understand the disease and improve treatment.
This trial studies blood and tissue samples from people with COPD, IPF, or lung cancer to find markers that can help diagnose and predict these conditions. It aims to discover why some lung diseases progress to cancer.
This trial collects tissue samples from your lung tumor and any tumors that have spread to other parts of your body. They will study the genetic makeup of these samples to better understand lung cancer and improve future treatments.
This study is evaluating a blood-based test that might detect lung cancer early, before symptoms appear. Researchers are looking for heavy smokers who have no signs of cancer, as well as those with suspicious lung nodules or confirmed lung cancer, to see if a simple blood draw could help identify cancer sooner.
This study is testing a new blood test that looks for DNA from lung cancer cells in your blood. It aims to see if the test can find lung cancer early, even before symptoms start.
Hear when a new Lung Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.